Alset Inc. (AEI): Nasdaq/NYSE listing notice — Alset Inc. receives Nasdaq bid-price deficiency notice; 180-day cure period

Alset Inc.

Received Nasdaq notice on April 15, 2024; bid price below $1 for 30 straight business days.
Has 180 days, until Oct 12, 2024, to regain compliance; needs $1 closing bid for 10 consecutive days.
Company evaluating actions to regain compliance; failure could lead to delisting.
Notice does not immediately delist; stock continues trading on Nasdaq Capital Market.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Alset Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 15, 2024, Alset Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the Company’s bid price was below the minimum $1 required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), Nasdaq has provided the Company with 180 calendar days, or until October 12, 2024, (

View on SEC.gov

Browse all listing & compliance notices →

Alset Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-015200

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.